Ovarian Cancer
A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients with Solid Tumors Likely to Express NaPi2b (MER-XMT-1536-1)
- Details
ClinicalTrials.gov ID:
NCT03319628
Diagnosis Type:
NA
USOR Number:
- Address
1800 N Williams St, Suite 200
Denver, CO 80218
P: (303) 388-4876